APOB and Insulin resistance: While the protection against insulin resistance seen in ApoB mice may be due to a reduction in the delivery of TAG to the muscle and reduced peripheral insulin resistance, it would be reasonable to speculate that animals with defective VLDL secretion may be slower to develop hepatic insulin resistance due to a reduction in DAG transportation from the ER to the plasma membrane.